✦ LIBER ✦

Prediction of patient discomfort during fibreoptic bronchoscopy

✍ Scribed by Tadahiko MITSUMUNE; Etsuo SENOH; Michifumi ADACHI

Book ID: 108964271
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 136 KB
Volume: 10
Category: Article
ISSN: 1323-7799
DOI: 10.1111/j.1440-1843.2005.00642.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Survey of chest physicians regarding pat

Survey of chest physicians regarding patient positioning and operator handedness during fibreoptic bronchoscopy

✍ Jovin John Mathew; Timothy Howes 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Absorption of lignocaine and bupivacaine

Absorption of lignocaine and bupivacaine from the respiratory tract during fibreoptic bronchoscopy.

✍ A. McBurney; DA Jones; PJ Stanley; JW Ward 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 666 KB

USE OF THE LARYNGEAL MASK AIRWAY TO FACI

USE OF THE LARYNGEAL MASK AIRWAY TO FACILITATE FIBREOPTIC BRONCHOSCOPY IN AWAKE PATIENTS

✍ J. Brimacombe; A. Berry 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Consequences of inflammatory processes o

Consequences of inflammatory processes on lignocaine protein binding during anaesthesia in fibreoptic bronchoscopy [letter]

✍ B. Bruguerolle; F. Philip-Joet; C. Arnaud; A. Arnaud 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 230 KB

A study of the use of ultrasonically neb

A study of the use of ultrasonically nebulized lignocaine for local anaesthesia during fibreoptic bronchoscopy

✍ R.I. Gove; J. Wiggins; D.E. Stableforth 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 787 KB

Concentration of meropenem in serum and

Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy

✍ E. Bergogne-Bérézin; C. Muller-Serieys; M. Aubier; M. C. Dombret 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 227 KB

The objective of the study was to evaluate the ability of meropenem to reach the bronchial lumen. 24 patients undergoing fibreoptic bronchoscopy for exploratory purposes were given a single dose of meropenem 1 g as an ( i.v., infusion over 30 min. Plasma (P) sampling times were: 0, 0.5, 1, 2 and 3 h